Carl Zeiss Meditec AG

Research Carl Zeiss Meditec AG (AFX) on Bullrun: market cap EUR 2.77B, P/E 23.1, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 2.77B; P/E is 23.1; dividend yield is 1.7%.

Peer valuation comparison

Latest P/E is 23.12x versus a Healthcare sector median of 24.46x (5.5% below).

Latest dividend yield is 1.7% versus a Healthcare sector median of 2.11% (19.4% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025EUR 2.20BEUR 120.62MEUR 176.27M52.2%n/aEUR 27.27MEUR 132.46MEUR 2.12B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27EUR 2.77B23.11.8%0.55

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.55 EUR, yield 1.7%.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters);

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Carl Zeiss Meditec AG's market cap?

Carl Zeiss Meditec AG's market capitalization is EUR 2.77B.

What is Carl Zeiss Meditec AG's P/E ratio?

Carl Zeiss Meditec AG's price-to-earnings (P/E) ratio is 23.1.

Does Carl Zeiss Meditec AG pay a dividend?

Carl Zeiss Meditec AG has a dividend yield of 1.7%.

What does Carl Zeiss Meditec AG do?

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery.